FundComb
Confirmed Control (100%) Closed Transaction verified Consumer Health

TheraTears and Akorn consumer health brands acquired by Prestige Consumer Healthcare

Prestige Consumer Healthcare acquired TheraTears and Akorn consumer health brands, a US consumer health brand, on Jul 1, 2021.

Transaction summary

Target
TheraTears and Akorn consumer health brands
Seller
Akorn
Announced
2021-05-27
Completed
2021-07-01
Geography
United States
Tags
Consumer Health
1 more tag
Consumer
Type
Acquisition
Deal type
Control
Stake acquired
100%
First added
2026-10-31
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 230M

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

3.83x

Period: Forecast 2020

Basis: Public source

EV / EBITDA

11.5x

EBITDA basis not stated

Basis: Public source

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: USD 230M

Basis

  • Reported value: US$230m. Multiples use revenue of US$60m (Forecast) and EBITDA of US$20m (Forecast).

Source summary

Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears

Confirmed

Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis

Open source

Continue your research

Related transaction comps

Explore more comps →
Consumer Health

Vitabiotics acquired by Bain Capital

2026-07-24 · Confirmed

View transaction → Consumer Health

Zywie Ventures Private Limited (OZiva) acquired by Hindustan Unilever Limited (HUL)

2026-02-12 · Confirmed

View transaction → Consumer Health

Kenvue acquired by Kimberly-Clark

2025-11-03 · Confirmed

View transaction → Consumer Health

Opella acquired by Clayton, Dubilier & Rice

2024-10-21 · Confirmed

View transaction →